Clinical Trials Logo

Clinical Trial Summary

Hearing loss maybe: -Symmetrical: in which the severity and pattern of hearing loss are the same in each ear. Or -Asymmetrical: is defined as binaural difference in bone conduction thresholds of >10 dB at two consecutive frequencies or >20 dB at one frequency (0.25-8.0 kHz), Poorer speech perception will often accompany poorer hearing and may be the reason for the patient's presentation .Unilateral or asymmetrical sensorineural hearing loss is important to discern, as it is an important risk factor for auditory nerve tumors (i.e. vestibular schwannoma) which is a life threatening condition, and in such cases further investigation is required (i.e. MRI scan) unless there is a known reason for the asymmetry, Several reports have recommended that further evaluation, especially expensive imaging studies, be conducted to rule out acoustic tumors when AHL is present


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05543135
Study type Observational
Source Sohag University
Contact Enas M Mahrous, resident doctor
Phone 01096769904
Email inas_mahmoud_post@med.sohag.edu.eg
Status Not yet recruiting
Phase
Start date September 20, 2022
Completion date September 2023

See also
  Status Clinical Trial Phase
Completed NCT02811549 - Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss N/A